Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06336642
Phase
PHASE2/PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Dyspnea

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SPOT-ON Early Start — BEHAVIORAL
    Participants will start treatment within 3 days of enrollment, which may include: receiving information on breathing techniques, relaxation techniques, posture techniques, and distraction techniques, and/or trying different oxygen-based therapies, such as high-flow nasal cannula, low-flow supplemental oxygen, and non-invasive ventilation with a respiratory therapist.
  • SPOT-ON Delayed Start — BEHAVIORAL
    Participants will start treatment within 3 days of enrollment, which may include: receiving information on breathing techniques, relaxation techniques, posture techniques, and distraction techniques, and/or trying different oxygen-based therapies, such as high-flow nasal cannula, low-flow supplemental oxygen, and non-invasive ventilation with a respiratory therapist.

Study Details

To learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.

Key Dates

Start date
Jun 11, 2024
Status verified
Mar 2026
Primary completion
Mar 31, 2030
Completion
Mar 31, 2032

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Group 1: SPOT-ON
    Participants will work with the healthcare team to find the best ways to reduce your shortness of breath by finding what combination of treatments work for participant. Participants will receive education about shortness of breath by the research staff in addition to information about standard treatments or medications for your shortness of breath that would be offered by your medical team.
  • Experimental: Group 2: SPOT-ON Waitlist
    Participants will work with the healthcare team to find the best ways to reduce your shortness of breath by finding what combination of treatments work for participant. Participants will receive education about shortness of breath by the research staff in addition to information about standard treatments or medications for your shortness of breath that would be offered by your medical team.

Primary Outcome Measure

Primary Outcome Measure: 1.Safety and adverse events (AEs) [ Time Frame: [Time Frame: Through study completion; an average of 1 year.] ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
David Hui, MD
[email protected]
713-792-6258

Find similar trials in Houston, TX

By research site
MD Anderson Cancer Center· Houston, TX

Related Studies